Serum Institute says claims surrounding COVISHIELD’s availability in 73 days are false

By Administrator_India

Capital Sands

Serum Institue of India  issued a statement on August 23, clarifying that all claims surrounding the availability of its COVID-19 vaccine, COVISHIELD, in 73 days are false.

“Presently, the government has granted us permission to only manufacture the vaccine and stockpile it for future use,” SII said in a statement they posted on Facebook, adding that COVISHIELD will be commercialised only after trials are proven successful and after all the requisite regulatory approvals are in place.

SII also touched on the Oxford-AstraZeneca vaccine. “The phase-3 trials for the Oxford-AstraZeneca vaccine are still underway. And only once the vaccine is proven immunogenic and efficacious, SII will confirm its availability, officially,” the company said.

Related Posts
117 new COVID-19 cases are reported in Mumbai, the most since February 25
COVID-19 cases

Mumbai reported 117 new coronavirus positive cases on Wednesday, the city’s highest one-day total since February 25, bringing the city’s Read more

Air India flights to Hong Kong cancelled till April 24 amid China’s COVID restrictions
Air India flights

Air India has canceled flights to Hong Kong between April 18-April 23, 2022, due to 'restrictions imposed by the Hong Read more

Covishield, Covaxin prices likely to be capped at Rs 275 per dose
COVID-19 vaccine booster doses

The prices of Covishield and Covaxin could be capped at Rs 275 per dose, with an additional service charge of Read more

US reports nearly 1 million COVID-19 cases in a day, setting global record
US reports nearly 1 million COVID-19 cases in a day setting global record

The United States reported nearly 1 million new coronavirus infections on Monday, the highest daily tally of any country in Read more

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x